Fig. 6.

Triptolide inhibits cervical cancer growth in vivo through cuproptosis. A Establishment of a xenograft model in nude mice and an experimental schematic diagram. The tumor tissues from four rows were taken from the control, low-dose triptolide (0.2 mg/kg), middle-dose triptolide (0.4 mg/kg), and high-dose triptolide (0.6 mg/kg) groups. B Tumor weights were measured after the mice were euthanized. C Tumor volume was assessed every 2 days. D, E Protein content of tumor tissues. (*p < 0.05, **p < 0.01, ***p < 0.001 versus the CON group; ns, not significant.)